Diorasis Therapeutics Corporation
Publicly observedWatertown, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
| City / locality | Watertown | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
| Name | Diorasis Therapeutics Corporation | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | P9NFFNZH4313 | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
Recorded events
- Grant30 Sept 2026Publicly observed
NIH SBIR/STTR award: Gene therapy to normalize intraocular pressure for the treatment of juvenile open angle glaucoma
USD 758,533.00 · National Eye Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.